Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs for Bronchopulmonary Dysplasia in Premature Infants
NCT03558334Phase 1Unknown
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Jun 2018
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of human umbilical cord derived mesenchymal stem cells in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: Number of participants with adverse reactions related to infusion after treatment at 24 hours. Status: unknown.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT03558334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03558334.